June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Regulation of SARS-CoV2 viral entry-related proteins in human ocular surface epithelium
Author Affiliations & Notes
  • Yuzuru Sasamoto
    Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, United States
    Transplant Research Program, Boston Children's Hospital, Boston, Massachusetts, United States
  • Catherine Lee
    Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, United States
    Transplant Research Program, Boston Children's Hospital, Boston, Massachusetts, United States
  • Masahito Yoshihara
    Biosciences and Nutrition, Karolinska Institutet, Stockholm, Stockholm, Sweden
  • Gabrielle Martin
    Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, United States
    Transplant Research Program, Boston Children's Hospital, Boston, Massachusetts, United States
  • Bruce Ksander
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Markus H Frank
    Transplant Research Program, Boston Children's Hospital, Boston, Massachusetts, United States
    Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, United States
  • Natasha Frank
    Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, United States
    Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Yuzuru Sasamoto, None; Catherine Lee, None; Masahito Yoshihara, None; Gabrielle Martin, None; Bruce Ksander, Rheacell GmbH & Co. KG (P), Ticeba GmbH (P); Markus Frank, Rheacell GmbH & Co. KG (P), Rheacell GmbH & Co. KG (C), Ticeba GmbH (P), Ticeba GmbH (C); Natasha Frank, Rheacell GmbH & Co. KG (P), Ticeba GmbH (P)
  • Footnotes
    Support  NIH/NEI grants 1K99EY031741 to Y.S., 1R01EY025794 and R24EY028767 to N.Y.F., B.R.K and M.H.F, NIH/NEI Schepens Core grant P30EY003790 to B.R.K., NIH/NIBIB grant 2T32EB016652-06 to C.A.A.L, Alcon Young Investigator Grant to Y.S., VA R&D Merit Review Award 1I01RX000989 and a Harvard Stem Cell Institute seed grant award to N.Y.F.
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 930. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuzuru Sasamoto, Catherine Lee, Masahito Yoshihara, Gabrielle Martin, Bruce Ksander, Markus H Frank, Natasha Frank; Regulation of SARS-CoV2 viral entry-related proteins in human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 2021;62(8):930.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). While the ocular surface is considered one of the major SARS-CoV2 transmission routes, SARS-CoV2 specific tropism in ocular epithelial cells is not fully understood. In the current study, we evaluated the expression of two SARS-CoV2 viral entry proteins, ACE2 and TMPRSS2, in human ocular epithelial cells. Additionally, we investigated the role of an eye-specific transcription factor PAX6 in regulating the expression of ACE2 and TMPRSS2.

Methods : Human donor corneas were obtained from the Saving Sight eye bank, Kansas City, MO. Flow cytometry was performed to detect ACE2 and TMPRSS2 in ABCB5-positive LSCs and ABCB5-negative limbal epithelial cells. RNAseq data of conjunctival swab samples were obtained from GSE135455 Gene Expression Omnibus datasets, and Spearman’s rank correlation coefficients between PAX6, ACE2 and TMPRSS2 were calculated using R version 4.0.3. RNAseq analyses of PAX6 overexpressing oral mucosal epithelial cells were obtained from the DNA Data Bank of Japan Sequence Read Archive (DRA002960). PAX6 knockdown (KD) was performed in cultured immortalized conjunctival epithelial cells using five distinct siRNAs. PAX6, ACE2, and TMPRSS2 expression was analyzed by qRT-PCR and Western blotting.

Results : Flow cytometry analyses revealed enhanced expression of ACE2 and TMPRSS2 in PAX6 low-expressing ABCB5-positive LSCs compared to PAX6 high-expressing ABCB5-negative limbal epithelial cells. Intriguingly, TMPRSS2 mRNA expression negatively correlated with PAX6 in conjunctival swab samples (R=-0.48, p<0.0001). Mechanistically, PAX6 overexpression in oral mucosal epithelial cells decreased TMPRSS2 mRNA levels by 76.8%, while PAX6 KD in immortalized conjunctival epithelial cells resulted in induction of TMPRSS2 RNA and protein expression suggesting a possible functional role of PAX6 in regulating TMPRSS2.

Conclusions : High expression of ACE2 and TMPRSS2 in LSCs raises the possibility of specific COVID-19 cellular tropism to this cell population. Based on the here reported novel role of PAX6 as a negative regulator of TMPRSS2 expression, lower levels of PAX6 might contribute to the induction of TMPRSS2 in LSCs. Our study points to the importance of COVID-19 testing of donor corneas before clinical transplantation to patients with limbal stem cell deficiency.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×